angiotensin ii, des-phe(8)- has been researched along with Breast Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Alabsi, W; Hay, M; Largent-Milnes, TM; Polt, R; Sulaiman, MI; Szabo, L; Vanderah, TW | 1 |
| Bujak-Gizycka, B; Bystrowska, B; Jawien, J; Kolton-Wroz, M; Kus, K; Madej, J; Olszanecki, R; Toton-Zuranska, J | 1 |
| Acconcia, F | 1 |
| Cai, C; Meng, X; Shen, Q; Tang, W; Wang, B; Wang, Y; Yu, C; Zou, F | 1 |
| Cook, KL; Gallagher, PE; Metheny-Barlow, LJ; Tallant, EA | 1 |
| diZerega, GS; Oliver, J; Rodgers, KE | 1 |
| Akyurek, S; Altundag, K; Altundag, O; Silay, K; Turen, S | 1 |
1 review(s) available for angiotensin ii, des-phe(8)- and Breast Cancer
| Article | Year |
|---|---|
The Network of Angiotensin Receptors in Breast Cancer.
Topics: Angiotensin I; Angiotensin II; Breast Neoplasms; Female; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2020 |
1 trial(s) available for angiotensin ii, des-phe(8)- and Breast Cancer
| Article | Year |
|---|---|
Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer.
Topics: Adult; Aged; Angiotensin I; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Maximum Tolerated Dose; Middle Aged; Peptide Fragments; Prospective Studies | 2006 |
5 other study(ies) available for angiotensin ii, des-phe(8)- and Breast Cancer
| Article | Year |
|---|---|
PNA6, a Lactosyl Analogue of Angiotensin-(1-7), Reverses Pain Induced in Murine Models of Inflammation, Chemotherapy-Induced Peripheral Neuropathy, and Metastatic Bone Disease.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cancer Pain; Disease Models, Animal; Female; Humans; Hyperalgesia; Mice; Mice, Inbred C57BL; Neuralgia; Oxaliplatin | 2023 |
Angiotensin 1-7 formation in breast tissue is attenuated in breast cancer - a study on the metabolism of angiotensinogen in breast cancer cell lines.
Topics: Angiotensin I; Angiotensinogen; Breast; Breast Neoplasms; Cell Line; Female; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2019 |
Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antigens, CD; Breast Neoplasms; Cadherins; Calcium Signaling; Cell Movement; Down-Regulation; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Heterografts; Humans; MCF-7 Cells; Mice, Inbred NOD; Mice, SCID; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Transplantation; NF-kappa B; p21-Activated Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; RNA Interference; Snail Family Transcription Factors; Transfection | 2016 |
Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Dual Specificity Phosphatase 1; Female; Fibronectins; Fibrosis; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Lung Diseases, Interstitial; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Transforming Growth Factor beta; Tumor Cells, Cultured | 2010 |
Angiotensin 1-7 and risk for breast cancer recurrence.
Topics: Angiotensin I; Breast Neoplasms; Cell Division; Peptide Fragments; Recurrence; Risk Factors | 2006 |